Carnitine for fatigue in multiple sclerosis (Q24197748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Carnitine for fatigue in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1

Aaron M Tejani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Michael Wasdell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Rae Spiwak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Greg Rowell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Shabita Nathwani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

16 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

CD007280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Serum carnitine and disabling fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Origin of fatigue in multiple sclerosis: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Antimyopathic effects of carnitine and nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Amantadine for fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Psychological aspects of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Aminopyridines for symptomatic treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

Fatigue in multiple sclerosis persists over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007280.PUB3

The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis.

21 January 2018

1 reference

12 December 2020

Increased urinary losses of carnitine during ifosfamide chemotherapy

1 reference

12 December 2020

Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system

1 reference

12 December 2020

Treatments for fatigue in multiple sclerosis: a rapid and systematic review

1 reference

12 December 2020

The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis

1 reference

12 December 2020

Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis

1 reference

12 December 2020

Fatigue in multiple sclerosis: current understanding and future directions.

1 reference

12 December 2020

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

1 reference

12 December 2020

Fatigue in multiple sclerosis: is the picture getting simpler or more complex?

1 reference

12 December 2020

Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue

1 reference

12 December 2020

Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.

1 reference

12 December 2020

L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.

1 reference

12 December 2020

Effects of multiple sclerosis on occupational and career patterns

1 reference

12 December 2020

Fatigue in Multiple Sclerosis

1 reference

12 December 2020

Amantadine therapy for fatigue in multiple sclerosis

1 reference

12 December 2020

Symptomatic fatigue in multiple sclerosis

1 reference

12 December 2020

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

1 reference

12 December 2020

The impact of fatigue on patients with multiple sclerosis.

1 reference

12 December 2020

10.1002/14651858.CD007280.PUB3

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1116238

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1116238

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592719%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

22592719

2 references

Consolidated OpenCitations Corpus – April 2017

1116238